Given prior evidence of elevated EP300 expression and H3K27ac enrichment in the lungs of PAH patients, we first sought to independently validate these findings and contextualize them within a broader chromatin regulatory framework. The gene discussed is EP300; the disease is pulmonary arterial hypertension.